Purification and characterization of a strain of coxsackievirus b4 of human origin that induces diabetes in mice

Nando K. Chatterjee, Catherine Nejman, Ivan Gerling

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

A diabetogenic strain of coxsackievirus B4 of human origin has been purified to study its biochemistry and diabetogenicity. Tissue culture cells infected with the virus contain two distinct types of particles—virions and membrane‐bound virions (MBV). MBVs are lighter (ρ = 1.29) than virions (ρ = 1.34), and they contain relatively more protein than RNA. Virions contain four capsid proteins, VP1–4, of various molecular weights: VP1, 37,500; VP2, 36,000; VP3, 26,000; and VP4, 5,500. MBVs contain three of these proteins and several additional proteins of molecular weights 45,000 to > 92,500, possibly of host or viral origin. The RNA in each type of particle is a 35s molecule; T1 oligonucleotide fingerprint profiles suggest minor differences in the two RNAs. Hybridization experiments show a great deal of sequence homology between the RNA of the diabetogenic strain and the RNA of prototype CB4, which does not induce overt diabetes. MBVs are 10‐ 70 times less infective than virions, yet they are more pathogenic in mice and induce significantly higher glucose intolerance (hyperglycemia). The hyperglycemic response appears to be lower in mice infected with both types of particles than in mice infected with MBVs alone. Thus, the two subpopulations of virions present in the diabetogenic strain differ biochemically and in their ability to induce diabetes.

Original languageEnglish (US)
Pages (from-to)57-69
Number of pages13
JournalJournal of Medical Virology
Volume26
Issue number1
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Enterovirus
Virion
RNA
Molecular Weight
Proteins
Glucose Intolerance
Dermatoglyphics
Capsid Proteins
Sequence Homology
Oligonucleotides
Hyperglycemia
Biochemistry
Cell Culture Techniques
Viruses

All Science Journal Classification (ASJC) codes

  • Infectious Diseases
  • Virology

Cite this

Purification and characterization of a strain of coxsackievirus b4 of human origin that induces diabetes in mice. / Chatterjee, Nando K.; Nejman, Catherine; Gerling, Ivan.

In: Journal of Medical Virology, Vol. 26, No. 1, 01.01.1988, p. 57-69.

Research output: Contribution to journalArticle

@article{faed77da9d554691a4eb21212658e95e,
title = "Purification and characterization of a strain of coxsackievirus b4 of human origin that induces diabetes in mice",
abstract = "A diabetogenic strain of coxsackievirus B4 of human origin has been purified to study its biochemistry and diabetogenicity. Tissue culture cells infected with the virus contain two distinct types of particles—virions and membrane‐bound virions (MBV). MBVs are lighter (ρ = 1.29) than virions (ρ = 1.34), and they contain relatively more protein than RNA. Virions contain four capsid proteins, VP1–4, of various molecular weights: VP1, 37,500; VP2, 36,000; VP3, 26,000; and VP4, 5,500. MBVs contain three of these proteins and several additional proteins of molecular weights 45,000 to > 92,500, possibly of host or viral origin. The RNA in each type of particle is a 35s molecule; T1 oligonucleotide fingerprint profiles suggest minor differences in the two RNAs. Hybridization experiments show a great deal of sequence homology between the RNA of the diabetogenic strain and the RNA of prototype CB4, which does not induce overt diabetes. MBVs are 10‐ 70 times less infective than virions, yet they are more pathogenic in mice and induce significantly higher glucose intolerance (hyperglycemia). The hyperglycemic response appears to be lower in mice infected with both types of particles than in mice infected with MBVs alone. Thus, the two subpopulations of virions present in the diabetogenic strain differ biochemically and in their ability to induce diabetes.",
author = "Chatterjee, {Nando K.} and Catherine Nejman and Ivan Gerling",
year = "1988",
month = "1",
day = "1",
doi = "10.1002/jmv.1890260109",
language = "English (US)",
volume = "26",
pages = "57--69",
journal = "Journal of Medical Virology",
issn = "0146-6615",
publisher = "Wiley-Liss Inc.",
number = "1",

}

TY - JOUR

T1 - Purification and characterization of a strain of coxsackievirus b4 of human origin that induces diabetes in mice

AU - Chatterjee, Nando K.

AU - Nejman, Catherine

AU - Gerling, Ivan

PY - 1988/1/1

Y1 - 1988/1/1

N2 - A diabetogenic strain of coxsackievirus B4 of human origin has been purified to study its biochemistry and diabetogenicity. Tissue culture cells infected with the virus contain two distinct types of particles—virions and membrane‐bound virions (MBV). MBVs are lighter (ρ = 1.29) than virions (ρ = 1.34), and they contain relatively more protein than RNA. Virions contain four capsid proteins, VP1–4, of various molecular weights: VP1, 37,500; VP2, 36,000; VP3, 26,000; and VP4, 5,500. MBVs contain three of these proteins and several additional proteins of molecular weights 45,000 to > 92,500, possibly of host or viral origin. The RNA in each type of particle is a 35s molecule; T1 oligonucleotide fingerprint profiles suggest minor differences in the two RNAs. Hybridization experiments show a great deal of sequence homology between the RNA of the diabetogenic strain and the RNA of prototype CB4, which does not induce overt diabetes. MBVs are 10‐ 70 times less infective than virions, yet they are more pathogenic in mice and induce significantly higher glucose intolerance (hyperglycemia). The hyperglycemic response appears to be lower in mice infected with both types of particles than in mice infected with MBVs alone. Thus, the two subpopulations of virions present in the diabetogenic strain differ biochemically and in their ability to induce diabetes.

AB - A diabetogenic strain of coxsackievirus B4 of human origin has been purified to study its biochemistry and diabetogenicity. Tissue culture cells infected with the virus contain two distinct types of particles—virions and membrane‐bound virions (MBV). MBVs are lighter (ρ = 1.29) than virions (ρ = 1.34), and they contain relatively more protein than RNA. Virions contain four capsid proteins, VP1–4, of various molecular weights: VP1, 37,500; VP2, 36,000; VP3, 26,000; and VP4, 5,500. MBVs contain three of these proteins and several additional proteins of molecular weights 45,000 to > 92,500, possibly of host or viral origin. The RNA in each type of particle is a 35s molecule; T1 oligonucleotide fingerprint profiles suggest minor differences in the two RNAs. Hybridization experiments show a great deal of sequence homology between the RNA of the diabetogenic strain and the RNA of prototype CB4, which does not induce overt diabetes. MBVs are 10‐ 70 times less infective than virions, yet they are more pathogenic in mice and induce significantly higher glucose intolerance (hyperglycemia). The hyperglycemic response appears to be lower in mice infected with both types of particles than in mice infected with MBVs alone. Thus, the two subpopulations of virions present in the diabetogenic strain differ biochemically and in their ability to induce diabetes.

UR - http://www.scopus.com/inward/record.url?scp=0023746461&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023746461&partnerID=8YFLogxK

U2 - 10.1002/jmv.1890260109

DO - 10.1002/jmv.1890260109

M3 - Article

C2 - 2846770

AN - SCOPUS:0023746461

VL - 26

SP - 57

EP - 69

JO - Journal of Medical Virology

JF - Journal of Medical Virology

SN - 0146-6615

IS - 1

ER -